Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marc Feldmann

Showing results (41-50 of 157) with videos related to

Pageof 16
Sort By:
Biochemical and Biophysical Research Communications|January 18, 2006
Vascular endothelial growth factor signalling in endothelial cell survival: a role for NFkappaBJennifer Grosjean, Serafim Kiriakidis, Kerri Reilly, et al.
The FEBS Journal|June 10, 2021
Collagen VI as a driver and disease biomarker in human fibrosisLynn Williams, Thomas Layton, Nan Yang, et al.
Arthritis Research|March 7, 2002
Cytokine-stimulated T cells induce macrophage IL-10 production dependent on phosphatidylinositol 3-kinase and p70S6K: implications for rheumatoid arthritisAndrew Foey, Patricia Green, Brian Foxwell, et al.
The Lancet. Rheumatology|February 1, 2021
Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatmentPhilip C Robinson, Duncan Richards, Helen L Tanner, et al.
Lancet (London, England)|March 28, 2022
Host-targeting oral antiviral drugs to prevent pandemicsRaymond A Dwek, John I Bell, Marc Feldmann, et al.
Journal of Leukocyte Biology|April 3, 2002
T cell-mediated signaling to vascular endothelium: induction of cytokines, chemokines, and tissue factorClaudia Monaco, Evangelos Andreakos, Sylvia Young, et al.
Current Drug Targets. Inflammation and Allergy|March 23, 2004
T-cell-mediated signalling in immune, inflammatory and angiogenic processes: the cascade of events leading to inflammatory diseasesClaudia Monaco, Evangelos Andreakos, Serafim Kiriakidis, et al.
Ebiomedicine|October 20, 2023
Allosteric TYK2 inhibition: redefining autoimmune disease therapy beyond JAK1-3 inhibitorsLise Torp Jensen, Kathrine E Attfield, Marc Feldmann, et al.
European Journal of Immunology|July 13, 2002
TNFalpha-induced macrophage chemokine secretion is more dependent on NF-kappaB expression than lipopolysaccharides-induced macrophage chemokine secretionCathleen J Ciesielski, Evangelos Andreakos, Brian M J Foxwell, et al.
The Journal of Clinical Investigation|March 3, 2007
A new JCI conflict-of-interest policyUshma S Neill, Craig B Thompson, Marc Feldmann, et al.
Pageof 16

Showing results (41-50 of 157) with videos related to

Sort By:
Pageof 16
Biochemical and Biophysical Research Communications|January 18, 2006
Vascular endothelial growth factor signalling in endothelial cell survival: a role for NFkappaBJennifer Grosjean, Serafim Kiriakidis, Kerri Reilly, et al.
The FEBS Journal|June 10, 2021
Collagen VI as a driver and disease biomarker in human fibrosisLynn Williams, Thomas Layton, Nan Yang, et al.
Arthritis Research|March 7, 2002
Cytokine-stimulated T cells induce macrophage IL-10 production dependent on phosphatidylinositol 3-kinase and p70S6K: implications for rheumatoid arthritisAndrew Foey, Patricia Green, Brian Foxwell, et al.
The Lancet. Rheumatology|February 1, 2021
Accumulating evidence suggests anti-TNF therapy needs to be given trial priority in COVID-19 treatmentPhilip C Robinson, Duncan Richards, Helen L Tanner, et al.
Lancet (London, England)|March 28, 2022
Host-targeting oral antiviral drugs to prevent pandemicsRaymond A Dwek, John I Bell, Marc Feldmann, et al.
Journal of Leukocyte Biology|April 3, 2002
T cell-mediated signaling to vascular endothelium: induction of cytokines, chemokines, and tissue factorClaudia Monaco, Evangelos Andreakos, Sylvia Young, et al.
Current Drug Targets. Inflammation and Allergy|March 23, 2004
T-cell-mediated signalling in immune, inflammatory and angiogenic processes: the cascade of events leading to inflammatory diseasesClaudia Monaco, Evangelos Andreakos, Serafim Kiriakidis, et al.
Ebiomedicine|October 20, 2023
Allosteric TYK2 inhibition: redefining autoimmune disease therapy beyond JAK1-3 inhibitorsLise Torp Jensen, Kathrine E Attfield, Marc Feldmann, et al.
European Journal of Immunology|July 13, 2002
TNFalpha-induced macrophage chemokine secretion is more dependent on NF-kappaB expression than lipopolysaccharides-induced macrophage chemokine secretionCathleen J Ciesielski, Evangelos Andreakos, Brian M J Foxwell, et al.
The Journal of Clinical Investigation|March 3, 2007
A new JCI conflict-of-interest policyUshma S Neill, Craig B Thompson, Marc Feldmann, et al.
Pageof 16